Cargando…

Tofacitinib treatment alters mucosal immunity and gut microbiota during experimental arthritis

Detalles Bibliográficos
Autores principales:	Hablot, Julie, Ferhat, Maroua, Lavelle, Aonghus, Salem, Fatouma, Taieb, Mahdia, Medvedovic, Jasna, Kindt, Nadège, Reboul, Pascal, Cailotto, Frédéric, Jouzeau, Jean‐Yves, Eberl, Gérard, Sokol, Harry, Moulin, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510778/ https://www.ncbi.nlm.nih.gov/pubmed/32997419 http://dx.doi.org/10.1002/ctm2.163

Ejemplares similares

Lack of protective effect of CCR3 blockade during experimental colitis may be related to CCR3 expression by colonic Tregs
por: Ferhat, Maroua, et al.
Publicado: (2021)

Emerging role of IκBζ in inflammation: Emphasis on psoriasis
por: Gautam, Preeti, et al.
Publicado: (2022)

Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice
por: Hablot, Julie, et al.
Publicado: (2017)

Inorganic pyrophosphate generation by transforming growth factor-beta-1 is mainly dependent on ANK induction by Ras/Raf-1/extracellular signal-regulated kinase pathways in chondrocytes
por: Cailotto, Frederic, et al.
Publicado: (2007)

Anti-Inflammatory Activity of Bryophytes Extracts in LPS-Stimulated RAW264.7 Murine Macrophages
por: Marques, Raíssa Volpatto, et al.
Publicado: (2022)

Baseline microbiota composition modulates antibiotic-mediated effects on the gut microbiota and host
por: Lavelle, Aonghus, et al.
Publicado: (2019)

Lack of Adiponectin Drives Hyperosteoclastogenesis in Lipoatrophic Mice
por: Madel, Maria-Bernadette, et al.
Publicado: (2021)

Tofacitinib
Publicado: (2012)

Erratum to Tofacitinib
Publicado: (2012)

Mucosal vaccines — fortifying the frontiers
por: Lavelle, Ed C., et al.
Publicado: (2021)

Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects
por: Shin, Wonsuk, et al.
Publicado: (2020)

Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2021)

Xylosyltransferase I mediates the synthesis of proteoglycans with long glycosaminoglycan chains and controls chondrocyte hypertrophy and collagen fibers organization of in the growth plate
por: Taieb, Mahdia, et al.
Publicado: (2023)

Tofacitinib is not a biologic
por: Marren, Amy S.
Publicado: (2017)

Mast cells in spondyloarthritis, more than simple inflammatory bystanders?
por: Polivka, Laura, et al.
Publicado: (2020)

Publisher Correction: Mucosal vaccines — fortifying the frontiers
por: Lavelle, Ed C., et al.
Publicado: (2021)

Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib
por: Inanc, Nevsun, et al.
Publicado: (2023)

Human γδ T-Cell Control of Mucosal Immunity and Inflammation
por: McCarthy, Neil E., et al.
Publicado: (2018)

Tofacitinib for refractory uveitis and scleritis
por: Paley, Michael A., et al.
Publicado: (2018)

Treatment of Multiorgan Sarcoidosis With Tofacitinib
por: Damsky, William, et al.
Publicado: (2020)

Tofacitinib in Hypertrophic Lichen Planus
por: SEIRINGER, Peter, et al.
Publicado: (2020)

Treatment of granuloma annulare with tofacitinib
por: Bosch‐Amate, Xavier, et al.
Publicado: (2022)

Compartmentalized multicellular crosstalk in lymph nodes coordinates the generation of potent cellular and humoral immune responses
por: Poirot, Justine, et al.
Publicado: (2021)

Microbiota and body weight control: Weight watchers within?
por: Boscaini, Serena, et al.
Publicado: (2021)

The Role of CD103(+) Dendritic Cells in the Intestinal Mucosal Immune System
por: Ruane, Darren Thomas, et al.
Publicado: (2011)

The Role of Tofacitinib in the Management of Alopecia Totalis
por: Hernandez-Montoya, Carlos, et al.
Publicado: (2019)

Tofacitinib in patients with refractory Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2020)

Topical tofacitinib in treatment of alopecia areata
por: Ferreira, Sineida Berbert, et al.
Publicado: (2020)

Effects of naringenin on the pharmacokinetics of tofacitinib in rats
por: Wang, Bo, et al.
Publicado: (2020)

Tofacitinib in Vogt-Koyanagi-Harada disease
por: Dutta Majumder, Parthopratim, et al.
Publicado: (2020)

Granulomatöse rosazeaartiges Exanthem unter Tofacitinib
por: Neumann, Kristina, et al.
Publicado: (2021)

Treatment of Resistant Alopecia areata with Tofacitinib
por: Avhad, Ganesh
Publicado: (2022)

Tofacitinib for the Treatment of Steroid-Induced Rosacea
por: Li, Tianhao, et al.
Publicado: (2022)

Resistant Alopecia Areata Treated with Tofacitinib
por: Sahay, Govind
Publicado: (2022)

Successful Treatment of Paediatric Morphea with Tofacitinib
por: TANG, Jun-Chi, et al.
Publicado: (2023)

Successful Use of Tofacitinib in Scleroderma Arthropathy
por: MV, Prakashini, et al.
Publicado: (2023)

Extended‐Release Once‐Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate‐Release Tofacitinib and Impact of Food
por: Lamba, Manisha, et al.
Publicado: (2016)

Macrophage migration inhibitory factor involvement in breast cancer (Review)
por: RICHARD, VINCENT, et al.
Publicado: (2015)

Systemic Tofacitinib Concentrations in Adult Patients With Atopic Dermatitis Treated With 2% Tofacitinib Ointment and Application to Pediatric Study Planning
por: Purohit, Vivek S., et al.
Publicado: (2018)

Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting
por: Long, Millie D, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k4lf7srg5h7md10qcqj7dslbm7